Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |